Clinical Trial Update: The Evicel Post-Authorization Surveillance Study

View source ↗

Summary

A post-authorization surveillance trial evaluating Evicel (fibrin sealant) sponsored by Ethicon has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage
• Peripheral Vascular Disease

Drugs mentioned

• Evicel

Snippet

Sponsor: Ethicon, Inc. | Conditions: Peripheral Vascular Disease, Hemorrhage | Status: COMPLETED | Results posted: 2015-08-19